Overview

Gender

male

Andreas Windemuth joined Cyclica Inc.as Chief Scientific Officer in 2016. Dr. Windemuth brings to Firefly 15 years of experience in computational biology.
Prior to joining Firefly, Dr. Windemuth served as Chief Technology Officer of Genomas, a company advancing DNA-Guided Medicine and personalized healthcare.
Prior to Genomas, he was Senior Director of Computational Research and Development at Genaissance Pharmaceuticals, where he was in charge of the development of haplotype sequencing algorithms.

Dr. Windemuth started his biotechnology career at CuraGen Corporation (New Haven, CT), where he was instrumental in developing many of the company's genomic technologies.
Dr. Windemuth is a fellow of the Boehringer Ingelheim Fonds (Stuttgart, Germany), and has done post-doctoral research on biomolecular modeling at the National Center for Supercomputing Applications (Urbana-Champaign, IL) and Columbia University (New York, NY).

Dr. Windemuth obtained his Ph.D. in theoretical physics from the Technical University of Munich